Rchr
J-GLOBAL ID：201801013918035276
Update date: Oct. 02, 2022
Miura Osamu
ミウラ オサム | Miura Osamu
Affiliation and department：
Job title：
Professor
Research field (1)：
Hematology and oncology
Papers (172)：
-
Daisuke Watanabe, Ayako Nogami, Keigo Okada, Hiroki Akiyama, Yoshihiro Umezawa, Osamu Miura. FLT3-ITD Activates RSK1 to Enhance Proliferation and Survival of AML Cells by Activating mTORC1 and eIF4B Cooperatively with PIM or PI3K and by Inhibiting Bad and BIM. Cancers (Basel). 2019. 11. 12
-
Kouhei Yamamoto, Shinya Abe, Ayaka Honda, Jun Hashimoto, Yuuki Aizawa, Sachiko Ishibashi, Taro Takemura, Nobutaka Hanagata, Masahide Yamamoto, Osamu Miura, et al. Fatty acid beta oxidation enzyme HADHA is a novel potential therapeutic target in malignant lymphoma. Lab. Invest. 2019
-
Masahide Yamamoto, Keisuke Tanaka, Yoshihiro Umezawa, Toshikage Nagao, Shigeo Toyota, Osamu Miura. Soluble Interleukin-2 Receptor Level at Diagnosis Predicts Prognosis of Patients With Follicular Lymphoma Irrespective of Initial Management Strategy. Anticancer Res. 2019. 39. 9. 5115-5122
-
Kota Yoshifuji, Yoshihiro Umezawa, Ayako Ichikawa, Ken Watanabe, Osamu Miura, Masahide Yamamoto. Methotrexate-associated Classical Hodgkin Lymphoma Shows Distinct Clinicopathological Features but Comparable Clinical Outcomes With Sporadic Cases. In Vivo. 2019. 33. 5. 1599-1604
-
Emi Uchida, Shihoko Suwa, Ryoto Yoshimoto, Ken Watanabe, Takeshi Kasama, Osamu Miura, Tetsuya Fukuda. TOPK is regulated by PP2A and BCR/ABL in leukemia and enhances cell proliferation. Int. J. Oncol. 2019
ｍore...
Professional career (1)：
Work history (2)：
- 2016/09/01 - 現在 Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences Medical and Dental Sciences Advanced Therapeutic Sciences Hematology
- 2000/04/01 - 2016/08/31 Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences Medical and Dental Sciences Advanced Therapeutic Sciences Hematology Professor
Return to Previous Page
